Monoallelic germline alterations of all previously identified downstream effectors in the FA pathways predispose to breast cancer, and the phenotype of patient cell lines is consistent with SLX4 being essential for DNA repair, which led to our hypothesis that monoallelic germline mutations in SLX4 might predispose carriers to breast cancer. This evidence concerns the gene SLX4 and breast cancer.